Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1989;80:1726-1736

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swedberg, S. H.
Right arrow Articles by Nicholls, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swedberg, S. H.
Right arrow Articles by Nicholls, S. C.

Circulation, Vol 80, 1726-1736, Copyright © 1989 by American Heart Association


ARTICLES

Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment

SH Swedberg, BG Brown, R Sigley, TN Wight, D Gordon and SC Nicholls
Department of Medicine, University of Washington School of Medicine, Seattle.

Failure of arteriovenous communications used for chronic hemodialysis was studied during sequential 5-year periods after placement of either endogenous Brescia-Cimino (B-C) fistulas (50 patients) or polytetrafluoroethylene (PTFE, Gore-Tex) grafts (66 patients). Venous stenosis near the anastomosis was the reason for failure in 45% of PTFE grafts compared with 16% of B-C fistulas (p less than 0.001). Failure occurred, on average, 16 months after PTFE graft placement compared with 22 for B-C fistulas (p = NS). Proximal vein segments removed from five failed and two functioning PTFE graft communications were studied using light and electron microscopy and immunocytochemical techniques. All venous segments removed during surgical shunt repair exhibited a marked intimal hyperplasia. The intimal cellular component was almost exclusively smooth muscle. Accumulation of intracellular lipid droplets was not seen. Foam cells as well as extracellular lipid deposits were absent; macrophages and lymphocytes were absent from the zone of proliferation. Ultrastructural examination revealed a large proportion of extracellular matrix surrounding smooth muscle cells in the neointima. Collagen and elastin were present in the extracellular matrix, in greatest concentration deeper in the intima. Closer to the lumen, most of the extracellular volume consisted of proteoglycan. Hemosiderin was absent from the lesions as were consistent signs of luminal and intimal fibrin. Uniform intimal gradients of actin, collagen, and proteoglycan suggest that this is a steadily progressive, rather than episodic, proliferative response. These clinical and histologic observations and an analysis of hemodynamic stresses support the postulate that upstream release of platelet-derived growth factor, and possibly, shear-induced intimal injury stimulate this response. This myointimal proliferative process provides a readily accessible model of fibromuscular hyperplasia in humans; its understanding may lead to effective methods for its prevention and may provide clues to the pathogenesis of arteriosclerosis.


This article has been cited by other articles:


Home page
RadiologyHome page
A. R. Forauer, E. K. Hoffer, and K. Homa
Dialysis Access Venous Stenoses: Treatment with Balloon Angioplasty--1- versus 3-minute Inflation Times1
Radiology, October 1, 2008; 249(1): 375 - 381.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. R. Chan, S. Bedi, R. J. Sanchez, H. N. Young, Y. T. Becker, P. S. Kellerman, and A. S. Yevzlin
Stent Placement Versus Angioplasty Improves Patency of Arteriovenous Grafts and Blood Flow of Arteriovenous Fistulae
Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 699 - 705.
[Abstract] [Full Text] [PDF]


Home page
Clin TrialsHome page
C. E. Lok, M. Allon, S. Donnelly, M. Dorval, B. Hemmelgarn, L. Moist, M. J. Oliver, M. Tonelli, and K. Stanley
Design of the fish oil inhibition of stenosis in hemodialysis grafts (FISH) study
Clinical Trials, August 1, 2007; 4(4): 357 - 367.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Sajgure, A. Choudhury, Z. Ahmed, and D. Choudhury
Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1390 - 1398.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Roy-Chaudhury, V. P. Sukhatme, and A. K. Cheung
Hemodialysis Vascular Access Dysfunction: A Cellular and Molecular Viewpoint
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1112 - 1127.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. D. Levit, R. M. Cohen, A. Kwak, R. D. Shlansky-Goldberg, T. W. I. Clark, A. A. Patel, S. W. Stavropoulos, J. I. Mondschein, J. A. Solomon, C. M. Tuite, et al.
Asymptomatic Central Venous Stenosis in Hemodialysis Patients
Radiology, March 1, 2006; 238(3): 1051 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Clin TrialsHome page
B. S Dixon, G. J Beck, L. M Dember, T. A Depner, J. J Gassman, T. Greene, J. Himmelfar, L. G Hunsicker, J. S Kaufman, J. H Lawson, et al.
Design of the Dialysis Access Consortium (DAC) Aggrenox prevention of access stenosis trial
Clinical Trials, October 1, 2005; 2(5): 400 - 412.
[Abstract] [PDF]


Home page
CirculationHome page
Z. Luo, G. Y. Akita, T. Date, C. Treleaven, K. A. Vincent, D. Woodcock, S. H. Cheng, R. J. Gregory, and C. Jiang
Adenovirus-Mediated Expression of {beta}-Adrenergic Receptor Kinase C-Terminus Reduces Intimal Hyperplasia and Luminal Stenosis of Arteriovenous Polytetrafluoroethylene Grafts in Pigs
Circulation, April 5, 2005; 111(13): 1679 - 1684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. A. Nath, S. K. R. Kanakiriya, J. P. Grande, A. J. Croatt, and Z. S. Katusic
Increased Venous Proinflammatory Gene Expression and Intimal Hyperplasia in an Aorto-Caval Fistula Model in the Rat
Am. J. Pathol., June 1, 2003; 162(6): 2079 - 2090.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. J. Wallace, J. W. Thomas, K. Ahrar, and K. C. Wright
Transrenal Arteriovenous Dialysis Graft Creation: Survival and Patency in a Swine Model
Radiology, May 1, 2003; 227(2): 501 - 509.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
V. Z. Erzurum, U. O. Hafeli, M. K. Hirko, S. P. Schmidt, and J. R. Rubin
Local Application of Beta-Particle Radiation to Reduce Venous Anastomotic Intimal Hyperplasia in Polytetrafluoroethylene Arteriovenous Fistulas
Vascular and Endovascular Surgery, September 1, 2000; 34(5): 377 - 383.
[Abstract] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. IKEGAYA, T. YAMAMOTO, A. TAKESHITA, T. WATANABE, K. YONEMURA, T. MIYAJI, K. OHISHI, M. FURUHASHI, Y. MARUYAMA, and A. HISHIDA
Elevated Erythropoietin Receptor and Transforming Growth Factor-{beta}1 Expression in Stenotic Arteriovenous Fistulae Used for Hemodialysis
J. Am. Soc. Nephrol., May 1, 2000; 11(5): 928 - 935.
[Abstract] [Full Text]


Home page
RadiologyHome page
S. O. Trerotola, T. J. Carmody, R. D. Timmerman, K. A. Bergan, R. G. Dreesen, S. V. Frost, and M. Forney
Brachytherapy for the Prevention of Stenosis in a Canine Hemodialysis Graft Model: Preliminary Observations
Radiology, September 1, 1999; 212(3): 748 - 754.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Brandl, T. Richter, K. Haug, M. G. Wilhelm, P. C. Maurer, and W. Nathrath
Topographic Analysis of Proliferative Activity in Carotid Endarterectomy Specimens by Immunocytochemical Detection of the Cell Cycle–Related Antigen Ki-67
Circulation, November 18, 1997; 96(10): 3360 - 3368.
[Abstract] [Full Text]


Home page
JAMAHome page
R. A. Hirth, M. N. Turenne, J. D. Woods, E. W. Young, F. K. Port, M. V. Pauly, and P. J. Held
Predictors of Type of Vascular Access in Hemodialysis Patients
JAMA, October 23, 1996; 276(16): 1303 - 1308.
[Abstract] [PDF]


Home page
CirculationHome page
C. Chen, S. G. Mattar, J. D. Hughes, G. F. Pierce, J. E. Cook, D. N. Ku, S. R. Hanson, and A. B. Lumsden
Recombinant Mitotoxin Basic Fibroblast Growth Factor–Saporin Reduces Venous Anastomotic Intimal Hyperplasia in the Arteriovenous Graft
Circulation, October 15, 1996; 94(8): 1989 - 1995.
[Abstract] [Full Text]


Home page
CLIN APPL THROMB HEMOSTHome page
Y. Erdem, I. C. Haznedaroglu, I. Celik, A. U. Yalcin, U. Yasavul, C. Turgan, S. Kirazli, and S. Caglar
Coagulation and Fibrinolysis in Amyloid and Non-amyloid Hemodialysis Patients: Assessment of Local Hemostatic Kinetics Within Arteriovenous Fistulas
Clinical and Applied Thrombosis/Hemostasis, October 1, 1996; 2(4): 279 - 284.
[Abstract] [PDF]


Home page
CirculationHome page
L. Hofstra, J. H.M. Tordoir, P. J.E.H.M. Kitslaar, A. P.G. Hoeks, and M. J.A.P. Daemen
Enhanced Cellular Proliferation in Intact Stenotic Lesions Derived From Human Arteriovenous Fistulas and Peripheral Bypass Grafts: Does It Correlate With Flow Parameters?
Circulation, September 15, 1996; 94(6): 1283 - 1290.
[Abstract] [Full Text]


Home page
VASC ENDOVASCULAR SURGHome page
V. Mickley, N. Rilinger, J. M. Friedrich, M. Storck, D. Abendroth, and L. Sunder-Plassmann
Intraoperative Stent Implantation for Venous Anastomotic Stenoses of Hemodialysis Grafts
Vascular and Endovascular Surgery, July 1, 1996; 30(4): 323 - 330.
[Abstract] [PDF]